Skip to main content
SpringerLink
Log in

Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The results of surgical treatment for advanced esophageal cancer remain extremely poor. Irradiation and chemotherapy are not superior to surgery. Perioperative morbidity and the influence on long-term survival of a combination of surgery and preoperative chemotherapy were investigated in patients with advanced esophageal cancer. Forty-nine patients with advanced esophageal squamous cell carcinoma were subjected to preoperative chemotherapy of cisplatin-5-fluorouracil. Fifty-seven patients were chosen as a historical control group who had not undergone chemotherapy before surgery but had the same histological stages as the chemotherapy group. The response to chemotherapy was assessed by histological studies of surgical specimens. The survival rates noted no significant difference between preoperative chemotherapy plus surgery and a resection alone. However, subclassification according to the grading of chemotherapeutic effectiveness showed that, compared with control, preoperative chemotherapy was beneficial to high responders (P=0.01), ineffective in low responders (P=0.61), and detrimental to nonresponders (P=0.03). Postoperative morbidity was significantly higher in the chemotherapy group than in the control group (P=0.02). These findings suggest that preoperative chemotherapy is necessary only for high responders and we therefore need to reliably identify non-, low, and high responders before chemotherapy to improve the survival and quality of life of patients with advanced esophageal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Daly JM, karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820–1828

    Article  CAS  PubMed  Google Scholar 

  2. Pree C, Aapro MS, Spiliopoulus A, Popowski Y, Mermillod B, Mirimanoff RO, Alberto P (1995) Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol 6:551–557

    PubMed  Google Scholar 

  3. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouim D, Boutin D, Campion JP, Launois B (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784

    Article  PubMed  Google Scholar 

  4. Japanese Society for Esophageal Disease (1992) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 8th edn. Kanchara, Tokyo, pp 59–93

    Google Scholar 

  5. Miller AB, Hoogstraten B, Staquet M, Wikler A (1981) Reporting results of cancer treatment. Cancer 42:207–214

    Article  Google Scholar 

  6. Schlag P, Herrmann V, Raeth V, Lehner B, Schwarz V, Herfarth C (1988) Preoperative chemotherapy in esophageal cancer. A phase 2 study. Acta Oncol 27:811–814

    Article  CAS  PubMed  Google Scholar 

  7. Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, Shields TW (1987) Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 60:2156–2160

    Article  CAS  PubMed  Google Scholar 

  8. Feliu J, Conzalez B, Garcia G, Espinosa E, Vicent JM, Gomez Navarro J, Berrocal A, Ordonez A, Vilches Y, de Castro J, Diaz J (1996) Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. Am J Clin Oncol 19:577–580

    Article  CAS  PubMed  Google Scholar 

  9. Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DW (1996) The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg 131:819–825

    CAS  PubMed  Google Scholar 

  10. Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin-B, Mountain C (1992) Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 28:880–884

    Article  Google Scholar 

  11. Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S (1988) Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 96:242–248

    CAS  PubMed  Google Scholar 

  12. Hilgenberg AD, Carey RW, Wilkins EW Jr, Choi-NC, Mathisen DJ, Grillo HC (1988) Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45:357–363

    Article  CAS  PubMed  Google Scholar 

  13. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, De Besi P, Gay F, Collette L, Sahmoud T (1997) Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33:1216–1220

    Article  CAS  PubMed  Google Scholar 

  14. Ilson D (1997) Toxicity of chemotherapy for esophageal carcinoma. Chest Surg Clin North Am 7:551–564

    CAS  Google Scholar 

  15. Mathew G, Jamieson GG (1997) Neoadjuvant therapy for oesophageal cancer. Br J Surg 84:1185–1187

    Article  CAS  PubMed  Google Scholar 

  16. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Cancer 73:2680–2686

    Article  CAS  PubMed  Google Scholar 

  17. Law S, Fok M, Chow S, Chu KM, Wong J (1997) Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg 114:210–217

    Article  CAS  PubMed  Google Scholar 

  18. Shibusawa H, Koshizuka S, Waki Y, Tuchiya I, Kobayashi N, Takazawa I, Nagashima T, Ueno I, Hosoya Y, Kanazawa K (1996) The existing stage of preoperative chemotherapy for advanced esophageal cancer in our hospital (in Japanese). Nippon Gekakeirengou Gakkai Zassi (J Jpn College Surg) 21:527

    Google Scholar 

  19. Okuma T, Yoshioka M, Isechi S, Kondo K, Tabira Y, Torigoe Y, Miyauchi Y (1994) Preoperative chemotherapy for esophageal cancer based on chemosensitivity testing. J Thorac Cardiovasc Surg 108:823–829

    CAS  PubMed  Google Scholar 

  20. Segalin A, Ruol A, Panozzo M, Bonavina L, Bianchi LC, Peracchia A (1993) Flow cytometric DNA analysis does not predict the radiochemoresponsiveness of esophageal cancer. J Surg Oncol 54:87–90

    Article  CAS  PubMed  Google Scholar 

  21. Lam KY, Law S, Ma LT, Ong SK, Wong J (1997) Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and P53 over espression predict chemoresponsiveness. Eur J Cancer 33:1221–1225

    Article  CAS  PubMed  Google Scholar 

  22. Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TP (1994) Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 74:1693–1698

    Article  CAS  PubMed  Google Scholar 

  23. Puglisi F, Di-Loreto C, Panizzo R, Avellini C, Fongione S, Cacitti V, Beltrami CA (1996) Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. J Clin Pathol 49:456–459

    Article  CAS  PubMed  Google Scholar 

  24. Imamura M, Shimada Y, Kanda Y, Fukumoto M, Yanagibashi K, Miyahara T, Tobe T (1992) Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer. Surg Today 22:409–415

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Jichi Medical School, 3311-1 Minami-Kawachi, 329-0498, Tochigi, Japan

    Yoshinori Hosoya, Hiroyuki Shibusawa, Hideo Nagai, Isao Ueno, Kazuya Sakuma, Toru Nagashima, Nobuhisa Kobayashi & Kyotaro Kanazawa

Authors
  1. Yoshinori Hosoya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroyuki Shibusawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideo Nagai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Isao Ueno
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuya Sakuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toru Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nobuhisa Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kyotaro Kanazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hosoya, Y., Shibusawa, H., Nagai, H. et al. Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect. Surg Today 29, 689–694 (1999). https://doi.org/10.1007/BF02482310

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482310

Key Words

Search

Navigation